Diabetes News Archive
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
The position statement by the ADA incorporates updates in treatment and screening for patients with diabetic retinopathy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.
Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
The document addresses important new issues in diabetes management, including metabolic surgery and a more specific definition of hypoglycemia.
Prediabetes does not always show clear symptoms; however, it can lead to type 2 diabetes, heart disease, or stroke.
Among all women, PPD risk increased with advanced age and gestational diabetes.
Fasting glucose is specific but not sensitive, and HbA1c is neither sensitive nor specific.
Researchers observed a high efficacy rate for both glyburide and metformin.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The most frequent enterovirus types included coxsackievirus A4, coxsackievirus A2, and coxsackievirus A16.
The study suggests that neither fish oil nor aspirin can be recommended for the prevention of AVF failure.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
The FDA has approved a continuous glucose monitoring system to replace fingerstick blood sugar testing in patients with diabetes.
Higher ambulatory volume was linked to lower quality of care and quality increased with higher diabetes-specific volume.
The position statement provides recommendations for psychosocial assessment and care of individuals with diabetes.
Risk was dependent on dose, background medications, and type of GLP-1 receptor agonist.
The continuous glucose monitoring system detected 81% of hypoglycemic events within 30 minutes.
Often underreported and undertreated, outcomes can be improved in this condition with appropriate screening and diagnosis.
Combining FFR with imaging techniques may be required to guide the treatment strategy in patients with high-risk, fast-progressing atherosclerosis.
The ADA releases its first independent recommendations on physical activity and exercise for all patients with diabetes.
Hepatic and peripheral insulin sensitivity in patients with type 2 diabetes were not affected by resveratrol treatment.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Individuals with prediabetes may reduce their risk of diabetes with stepwise diabetes prevention.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.
Patients with type 2 diabetes with systolic blood pressure lower than 140 mm Hg have a lower risk of cardiovascular events.
The once-daily injection works to improve glycemic control.
Patients with prediabetes who briskly walked saw greater improvements in oral glucose tolerance compared with those who jogged.
A meta-analysis of the 9 classes of glucose-lowering drugs supports the ADA's recommendation of metformin monotherapy as preferred initial treatment.
Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Reductions in disease risk were observed for an intake as high as 7.5 servings of whole grains per day.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
Use of the Glucommander was linked to a shorter time to achieving blood glucose levels lower than 200 mg/dL.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Glucocorticoid therapy in patients with rheumatoid arthritis has been linked to elevated risk of diabetes.
Pediatric patients with type 1 diabetes often have low levels of vitamin D.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
From 1980 to 2014, the number of people worldwide with diabetes has increased from 108 million to 422 million.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
High body fat percentage and low BMI are associated with increased mortality in women and men.
Treatment guidelines must expand to focus on patients co-infected with both HCV and HIV.
Very few patients with glycated hemoglobin levels that indicate prediabetes are being told they have the condition.
High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.
The CPAP group had a larger decrease in HbA1c levels after 6 months.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Eating more potatoes before pregnancy may be associated with greater risk of gestational diabetes mellitus,
A statin plus extended-release niacin reduces apoB-48 concentrations in patients with type 2 diabetes, compared with a statin alone.
Premature birth has been associated with a number of adverse health conditions.
Intranasal glucagon is noninferior to intramuscular glucagon in adults with type 1 diabetes.
More than 60% of the 31,545 patients analyzed between 2001 and 2013 underwent HbA1c at least four times per year.
Research shows that adding metformin to insulin therapy will not boost glycemic control in overweight teens with type 1 diabetes.
Breastfeeding for 2 or more months may reduce the odds of developing type 2 diabetes in mothers previously diagnosed with gestational diabetes.
Three renal biomarkers - AKI, albuminuria, and eGFR - can predict adverse outcomes in diabetes, according to a study published in Diabetes Care.
In adolescents with type 1 or type 2 diabetes, the rates of diagnosed depression are lower than the number of patients reporting depressive symptoms.
Diabetes remains prevalent in the United States, with an estimated rate of 12% to 14% among adults.
The FDA has approved two new treatments, Tresiba and Ryzodeg, for both type 1 and type 2 diabetes.
Daytime sleepiness and long naps may be associated with significantly increased risks of developing type 2 diabetes.
Exposure to any type of pesticide raised the risk of developing any type of diabetes by 61%.
Compared with men with diabetes, women with diabetes have a 34% higher risk of experiencing cardiovascular events.
Almost half of adults in the United States have either type 2 diabetes or prediabetes, though many are undiagnosed.
The majority of older adults with diabetes do not meet the ADA's criteria for good management of their condition.
Using long-acting insulin in type 2 diabetes does not increase the risk for acute myocardial infarction.
For people with type 1 diabetes, using insulin pump therapy lowers mortality from all causes.
People with type 2 diabetes who skipped breakfast had a higher risk of postprandial hyperglycemia.
Glyburide is associated with an increased risk of adverse neonatal outcomes compared to insulin in women with gestational diabetes.
Blood glucose meters may not adhere to FDA standards for low glycemic ranges.
Alefacept, a psoriasis treatment, can help preserve pancreas function in type 1 diabetes.
Diabetes patients who had a greater number of diabetes-related complications had an increased risk for dementia.
People with more than one major health problem have higher mortality than those with just one condition.
For patients with diabetes, strict glucose control lowers the risk for cardiovascular events.
Eating carbohydrates last helped lower glucose levels, especially if vegetables and proteins were eaten first.
Clinicians who take more electronic notes on lifestyle counseling help their diabetic patients achieve lower HbA1c.
Patients with subclinical hypothyroidism who take statins have an increased risk of developing diabetes.
After adjustment for age and sex, standardized mortality ratios (SMRs) were higher in type 1 and type 2 diabetes for all outcomes.
Strengthening patient-provider communication can improve diabetes outcomes.
With metformin, mean score for gastrointestinal side effects higher for gastritis subjects over four weeks.
The glycated hemoglobin in the intensive control group was 6.9%, on average. For those on standard care, the glycated hemoglobin average was 8.4%.
Patients taking the highest amount of metformin had a 25% reduced risk of developing OAG compared with those not taking the medication.
Excess weight and sleep issues are more common among those with changing schedules.
Antipsychotic medications increase a child's risk of developing type 2 diabetes by up to 50%.
Independent mortality predictors included older age, male sex, renal disease, stroke, cancer, COPD, and congestive heart failure.
The report focuses on diabetes care concepts, which include patient centeredness, diabetes across the life span, and advocacy for patients with diabetes.
The most effective intervention for reducing the features of metabolic syndrome is dietary carbohydrate restriction.
Few who were not recognized as having diabetes during hospitalization were on medications 6 months after discharge.
Regardless of lipid-lowering therapy, patients on fish oil supplementation had lower urinary 11-dehydrothromboxane B2 levels.
Under guidelines from the American College of Obstetricians and Gynecologists, women are screened for gestational diabetes, usually at 24 to 28 weeks.
More than 200 generic medications are available for $4 and more than 400 generic prescriptions are available for $10.
Significant symptoms of depression were identified in 20% of women with gestational diabetes mellitus and 13% of women without gestational diabetes mellitus.
Of the 49,653 patients included in the cohort, 562 were hospitalized for community-acquired pneumonia during follow-up.
Without insurance, insulin costs $120 to $400 per month, which can be a substantial barrier to many patients with diabetes.
The FDA has granted expanded the use of Eylea injection to treat diabetic retinopathy in patients with diabetic macular edema (DME).
There was a 23% increase in the number of Medicaid-enrolled patients with newly identified diabetes in the 26 states and the D.C. that expanded Medicaid, compared with a 0.4% increase in the 24 states that did not expand Medicaid.
Both bariatric surgery and intensive weight management yielded similar improvements in HbA1c, weight loss and quality of life.
Raised risk for increased baseline BMI, most recent BMI, and weight gain after gestational diabetes